Annual Total Expenses
$2.11 B
+$287.98 M+15.80%
31 December 2023
Summary:
Alnylam Pharmaceuticals annual total expenses is currently $2.11 billion, with the most recent change of +$287.98 million (+15.80%) on 31 December 2023. During the last 3 years, it has risen by +$789.18 million (+59.73%). ALNY annual total expenses is now at all-time high.ALNY Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$577.82 M
-$33.39 M-5.46%
30 September 2024
Summary:
Alnylam Pharmaceuticals quarterly total expenses is currently $577.82 million, with the most recent change of -$33.39 million (-5.46%) on 30 September 2024. Over the past year, it has increased by +$41.16 million (+7.67%). ALNY quarterly total expenses is now -5.46% below its all-time high of $611.21 million, reached on 30 June 2024.ALNY Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALNY Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +15.8% | +7.7% |
| 3 y3 years | +59.7% | +56.5% |
| 5 y5 years | +137.2% | +101.8% |
ALNY Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +59.7% | -5.5% | +60.5% |
| 5 y | 5 years | at high | +137.2% | -5.5% | +101.8% |
| alltime | all time | at high | >+9999.0% | -5.5% | >+9999.0% |
Alnylam Pharmaceuticals Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $577.82 M(-5.5%) |
| June 2024 | - | $611.21 M(+13.7%) |
| Mar 2024 | - | $537.77 M(-3.3%) |
| Dec 2023 | $2.11 B(+15.8%) | $556.12 M(+3.6%) |
| Sept 2023 | - | $536.66 M(-2.2%) |
| June 2023 | - | $548.59 M(+16.9%) |
| Mar 2023 | - | $469.10 M(-10.4%) |
| Dec 2022 | $1.82 B(+17.4%) | $523.65 M(+0.2%) |
| Sept 2022 | - | $522.35 M(+25.4%) |
| June 2022 | - | $416.50 M(+15.7%) |
| Mar 2022 | - | $359.99 M(-20.5%) |
| Dec 2021 | $1.55 B(+17.5%) | $453.10 M(+22.7%) |
| Sept 2021 | - | $369.31 M(+0.7%) |
| June 2021 | - | $366.71 M(+0.8%) |
| Mar 2021 | - | $363.82 M(+1.7%) |
| Dec 2020 | $1.32 B(+14.0%) | $357.78 M(+1.9%) |
| Sept 2020 | - | $351.05 M(+15.9%) |
| June 2020 | - | $302.82 M(-2.2%) |
| Mar 2020 | - | $309.63 M(-16.3%) |
| Dec 2019 | $1.16 B(+30.3%) | $369.75 M(+29.1%) |
| Sept 2019 | - | $286.36 M(+1.9%) |
| June 2019 | - | $280.99 M(+26.5%) |
| Mar 2019 | - | $222.08 M(-8.0%) |
| Dec 2018 | $889.58 M(+50.8%) | $241.39 M(-5.9%) |
| Sept 2018 | - | $256.63 M(+15.5%) |
| June 2018 | - | $222.26 M(+31.3%) |
| Mar 2018 | - | $169.30 M(-8.6%) |
| Dec 2017 | $590.00 M(+25.1%) | $185.23 M(+29.6%) |
| Sept 2017 | - | $142.90 M(+4.8%) |
| June 2017 | - | $136.41 M(+8.7%) |
| Mar 2017 | - | $125.47 M(-5.6%) |
| Dec 2016 | $471.75 M(+39.9%) | $132.89 M(+10.4%) |
| Sept 2016 | - | $120.33 M(+18.9%) |
| June 2016 | - | $101.16 M(-13.8%) |
| Mar 2016 | - | $117.37 M(+17.3%) |
| Dec 2015 | $337.11 M(+43.6%) | $100.06 M(+18.2%) |
| Sept 2015 | - | $84.65 M(+3.7%) |
| June 2015 | - | $81.63 M(+15.4%) |
| Mar 2015 | - | $70.76 M(+1.5%) |
| Dec 2014 | $234.78 M(+67.6%) | $69.73 M(+24.1%) |
| Sept 2014 | - | $56.17 M(-0.0%) |
| June 2014 | - | $56.19 M(+6.7%) |
| Mar 2014 | - | $52.68 M(+30.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | $140.11 M(+7.5%) | $40.44 M(-1.9%) |
| Sept 2013 | - | $41.23 M(+37.4%) |
| June 2013 | - | $30.00 M(+5.5%) |
| Mar 2013 | - | $28.45 M(-10.7%) |
| Dec 2012 | $130.29 M(-5.3%) | $31.85 M(-8.8%) |
| Sept 2012 | - | $34.91 M(+5.9%) |
| June 2012 | - | $32.95 M(+7.7%) |
| Mar 2012 | - | $30.59 M(-10.1%) |
| Dec 2011 | $137.57 M(-4.3%) | $34.04 M(+2.4%) |
| Sept 2011 | - | $33.23 M(-1.5%) |
| June 2011 | - | $33.73 M(-7.8%) |
| Mar 2011 | - | $36.57 M(+9.9%) |
| Dec 2010 | $143.78 M(-3.3%) | $33.27 M(-8.6%) |
| Sept 2010 | - | $36.40 M(-4.8%) |
| June 2010 | - | $38.24 M(+6.6%) |
| Mar 2010 | - | $35.87 M(+3.4%) |
| Dec 2009 | $148.64 M(+19.9%) | $34.70 M(+2.3%) |
| Sept 2009 | - | $33.90 M(-27.9%) |
| June 2009 | - | $47.01 M(+42.3%) |
| Mar 2009 | - | $33.04 M(+2.5%) |
| Dec 2008 | $124.00 M(-13.9%) | $32.22 M(+11.2%) |
| Sept 2008 | - | $28.97 M(-21.0%) |
| June 2008 | - | $36.66 M(+40.2%) |
| Mar 2008 | - | $26.15 M(+23.8%) |
| Dec 2007 | $144.07 M(+116.9%) | $21.12 M(-68.8%) |
| Sept 2007 | - | $67.65 M(+180.9%) |
| June 2007 | - | $24.09 M(-22.8%) |
| Mar 2007 | - | $31.21 M(+83.9%) |
| Dec 2006 | $66.43 M(+35.1%) | $16.97 M(+0.9%) |
| Sept 2006 | - | $16.82 M(-1.8%) |
| June 2006 | - | $17.13 M(+10.4%) |
| Mar 2006 | - | $15.51 M(-5.8%) |
| Dec 2005 | $49.19 M(+34.6%) | $16.47 M(+36.3%) |
| Sept 2005 | - | $12.08 M(-1.9%) |
| June 2005 | - | $12.31 M(+47.9%) |
| Mar 2005 | - | $8.32 M(+1.8%) |
| Dec 2004 | $36.54 M(+77.2%) | $8.18 M(+4.9%) |
| Sept 2004 | - | $7.79 M(+9.7%) |
| June 2004 | - | $7.11 M(-47.2%) |
| Mar 2004 | - | $13.47 M(+654.8%) |
| Dec 2003 | $20.62 M(+388.5%) | - |
| June 2003 | - | $1.78 M(+40.9%) |
| Mar 2003 | - | $1.27 M |
| Dec 2002 | $4.22 M | - |
FAQ
- What is Alnylam Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals annual total expenses year-on-year change?
- What is Alnylam Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals quarterly total expenses year-on-year change?
What is Alnylam Pharmaceuticals annual total expenses?
The current annual total expenses of ALNY is $2.11 B
What is the all time high annual total expenses for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high annual total expenses is $2.11 B
What is Alnylam Pharmaceuticals annual total expenses year-on-year change?
Over the past year, ALNY annual total expenses has changed by +$287.98 M (+15.80%)
What is Alnylam Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of ALNY is $577.82 M
What is the all time high quarterly total expenses for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high quarterly total expenses is $611.21 M
What is Alnylam Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, ALNY quarterly total expenses has changed by +$41.16 M (+7.67%)